by Option Review - January 28th, 2013 1:26 pm
by Option Review - January 28th, 2013 1:26 pm
December 5th, 2016 3:49 am
Courtesy of Mish.
Axel Weber, former head of Germany’s central bank says the ECB is going to halt QE soon and hike rates by September.
Weber warns Markets Unprepared for Central Bank Shifts.
Investors are dangerously unprepared for a sharp rise in eurozone bond yields when US interest rates march higher and European quantitative easing ends, Axel Weber, chairman of UBS and the former head of the Bundesbank, has warned.
The jump in US rates could spark big jolts in the markets as the long spell of aggressive monetary easing across the globe has left many investors off-guard over a swi...
December 5th, 2016 3:29 am
Fitch Ratings' outlook for the Chinese banking sector in 2017 is negative, reflecting our view that weak profitability and strong credit growth will keep capitalisation under pressure. High and rising leverage in the corporate sector remains a key risk facing China's banks.
China's debt-resolution timeline is being pushed back by measures to lessen the debt burden on corporate borrowers - including low interest rates, loan rollovers, debt-for-equity swaps and a loosening of prudential controls. Leverage wi...
December 4th, 2016 11:26 pm
By Independent Trader. Originally published at ValueWalk.
On paper, central banks are responsible for two things. They decide about the supply of currency and set interest rates. If the economy is healthy the velocity of money circulation grows higher creating inflation. Raising interest rates help to cool off the overheating economy. On the other hand, if the economy is heading for a recession central banks lower interest rates to make available to society credit cheaper and stimulate spending. This helps the economy get up from its knees. This is the theory.
Historically we see that central banks kept interest rates very low not to prevent economies from apathy but to create ...
December 4th, 2016 10:56 pm
Courtesy of Blain.The week that was…
The market needed a pause after the frenetic post election rally, and it finally arrived this week. The pullback was mild as bulls would like. This week’s “fear of the week” was Italy’s political referendum which happened today… and was rejected.
Italian voters were asked in a referendum to approve changes to the country’s constitution, which have been called the most sweeping since the end of World War II. The proposed reforms would cut the Senate’s size by two-thirds and reduce powers held by the country’s 20 regional governments. Italian Prime Minister Matteo Renzi believes the changes will aid efficiency in parliament.
The reforms could also “make it easier to implement important legislation (such as measure...
December 4th, 2016 10:24 pm
Financial Markets and Economy
Italian prime minster Matteo Renzi went down in flames in a crushing defeat of a referendum he sponsored.
Sergio Mattarella, Italy’s president, has a choice. President is largely a symbolic position but what happens next is up to Mattarella.
The president may ask Renzi to hang on in a caretaker role, there could be snap elections, there could be a fourth technocrat government. Renzi was the third consecutive appointed technocrat prime minister.
December 3rd, 2016 11:00 pm
Courtesy of Benzinga.Related XLV Best Sector ETFs for December: A Repeat Offender Why Sector ETFs May Be Better Than Individual Stocks ...
December 3rd, 2016 10:21 am
Courtesy of Chris Kimble.
Below looks at the S&P 500/Govt Bond (TLT) Ratio over the past 12-years
CLICK ON CHART TO ENLARGE
The S&P 500/TLT ratio is now back at 2007 levels. Double Top or Breakout Time.
Do find this interesting at this time, bullish sentiment on $TLT now stand around the 10% level, which happens to be the same level it was in mid 2007!
Different this time??? Always fun friends!!!...
December 3rd, 2016 8:30 am
Courtesy of Nattering Naybob.Over at Philstockworld... High Finance for Real People - Fun and Profits...
November 28th, 2016 9:19 am
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...
November 21st, 2016 8:05 pm
Last Thursday we reported that in a startling development seeking to breach the privacy veil of users of America's largest bitcoin exchange, the IRS filed court papers seeking a judicial order to serve a so-called “John Doe” summons on the San Francisco-based Bitcoin platform Coinbase.
The government’s request is part of a bitcoin tax-evasion probe, and se...
October 7th, 2016 2:29 pm
Good article on investing success:The Most Overlooked Trait of Investing Success
There is a reason no Berkshire Hathaway investor chides Buffett when the company has a bad quarter. It’s because Buffett has so thoroughly convinced his investors that it’s pointless to try to navigate around 90-day intervals. He’s done that by writing incredibly lucid letters to investors for the last 50 years, communicating in easy-to-understand language at annual meetings, and speaking on TV in ways that someone with no investing experience can grasp.
Yes, Buffett runs an amazing investment company. But he also runs an amazing investor company. One of the most underappreciated part of his s...
August 22nd, 2016 1:15 pm
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Epizyme was founded in 2007, and trying to create drugs to treat patient's cancer by focusing on genetically-linked differences between normal and cancer cells. Cancer areas of focus include leukemia, Non-Hodgkin's lymphoma and breast cancer. One of the Epizme cofounders, H. Robert Horvitz, won the Nobel Prize in Medicine in 2002 for "discoveries concerning genetic regulation of organ development and programmed cell death."
Before discussing the drug targets of Epizyme, understanding epigenetics is crucial to comprehend the company's goals.
Genetic components are the DNA sequences that are 'inherited.' Some of these genes are stronger than others in their expression (e.g., eye color). Yet, some genes turn on or off due to external factors (environmental), and it is und...
May 13th, 2016 2:40 pm
Reminder: Harlan is available to chat with Members, comments are found below each post.
December 15th, 2015 2:15 pm
We know you love coming here for our Stocks & Options education, strategy and trade ideas, and for Phil's daily commentary which you can't live without, but there's more!
PhilStockWorld.com features the most important and most interesting news items from around the web, all day, every day!
News: If you missed it, you can probably find it in our Market News section. We sift through piles of news so you don't have to.
If you are looking for non-mainstream, provocatively-narrated news and opinion pieces which promise to make you think -- we feature Zero Hedge, ...
Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...